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Function of glycosyltransferase genes involved in urdamycin A
biosynthesis
A Trefzer1*, D Hoffmeister1*, E Künzel2, S Stockert1, G Weitnauer1,
L Westrich1, U Rix2, J Fuchser3, KU Bindseil3, J Rohr2 and A Bechthold1
Background: Urdamycin A, the principle product of Streptomyces fradiae
Tü2717, is an angucycline-type antibiotic. The polyketide-derived aglycone
moiety is glycosylated at two positions, but only limited information is available
about glycosyltransferases involved in urdamycin biosynthesis.
Results: To determine the function of three glycosyltransferase genes in the
urdamycin biosynthetic gene cluster, we have carried out gene inactivation and
expression experiments. Inactivation of urdGT1a resulted in the predominant
accumulation of urdamycin B. A mutant lacking urdGT1b and urdGT1c mainly
produced compound 100-2. When urdGT1c was expressed in the
urdGT1b/urdGT1c double mutant, urdamycin G and urdamycin A were
detected. The mutant lacking all three genes mainly accumulated aquayamycin
and urdamycinone B. Expression of urdGT1c in the triple mutant led to the
formation of compound 100-1, whereas expression of urdGT1a resulted in the
formation of compound 100-2. Co-expression of urdGT1b and urdGT1c
resulted in the production of 12b-derhodinosyl-urdamycin A, and co-expression
of urdGT1a, urdGT1b and urdGT1c resulted in the formation of urdamycin A. 
Conclusions: Analysis of glycosyltransferase genes of the urdamycin
biosynthetic gene cluster led to an unambiguous assignment of each
glycosyltransferase to a certain biosynthetic saccharide attachment step.
Introduction
Recently, many research groups have started to manipulate
polyketide biosynthetic pathways, attempting to produce
hybrid or novel antibiotics. Work from a number of labora-
tories has shown that it is possible to combine individual
polyketide synthase (PKS) domains that govern synthesis
of different aromatic polyketides [1–5]. An important
source of diversity in natural products is the range of sugars
attached to specific positions of an aglycone core. These
sugar components have almost invariably been found to be
involved in the molecular recognition between the antibi-
otic and its cellular target [6,7]. Urdamycin A (Figure 1), an
angucycline-type antibiotic and anticancer agent [8], is the
principle product of Streptomyces fradiae Tü2717. It consists
of aquayamycin, which contains a C-glycosidically linked
D-olivose, and three additional O-glycosidically linked
deoxysugars: two L-rhodinoses and another D-olivose.
Other metabolites produced by S. fradiae Tü2717 are
12b-derhodinosyl-urdamycin A, urdamycin B, urdamycin C
and urdamycin D [8]. Genes encoding the PKS involved in
the formation of urdamycin and genes involved in tailoring
reactions have been cloned and sequenced [9–13]. Inactiva-
tion of one gene, urdGT2, created a mutant that produced
three new urdamycins (urdamycin I, urdamycin J and
urdamycin K), all of which  lack the C-glycosidically linked
saccharide sidechain. This result indicates that UrdGT2
catalyzes the earliest glycosyltransfer step in the urdamycin
biosynthesis (the C-glycosyltransfer of one dNDP-olivose
moiety [12,13]). As the next step to analyse the formation
and attachment of the other three deoxysugar moieties, we
cloned and sequenced more of the urdamycin biosynthetic
cluster. Three genes encoding glycosyltransferases were
detected. Here we report their sequences and the results of
gene inactivation and expression experiments, which have
allowed us to assign the individual functions of each glyco-
syltransferase of the urdamycin cluster.
Results
Cloning and sequencing of urdGT1a, urdGT1b, urdGT1c,
and other genes in the urdamycin biosynthetic gene cluster
Previously, it was shown that cosmid purd8 carries the PKS
genes of the urdamycin biosynthetic cluster [10]. An 8.5 kb
DNA fragment of purd8 was sequenced. In total, six open
reading frames (orf157, orf355, urdGT1a, urdGT1b, urdInt
and urdGT1c) with characteristics of Streptomyces genes
(overall G+C content of 67% and a high bias towards G
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Figure 1
Structures of aromatic polyketides produced by (a) wild-type S. fradiae Tü2717 and by (b) the Ax mutant, (c) the 16-14 mutant and (d) the
D331-9 mutant of S. fradiae Tü2717 generated in this study. 
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and C at the third codon position) and a plausible ribo-
some-binding site were identified (Figure 2). Orf157
encodes a hypothetical 17.125 kDa protein of 157 amino
acids (aa), which has highest homology to StgU of Strepto-
myces anulatus [14]. Orf355 appears to encode a 355 aa
protein (33.622 kDa), of which an 82 aa portion shows 36%
identity to SC5C7.06 of Streptomyces coelicolor A3 [15], a
putatively secreted protein. There is a 34 bp sequence
nearly identical to the rp3 actinophage attachment site
between orf355 and urdGT1a [16]. The urdGT1a gene is
1281 base pairs, and a TTG triplet is thought to be the ini-
tiation codon. The deduced protein is 426 aa and has a
molecular weight of 46.747 kDa. UrdGT1a is most similar
(42% identical at the amino acid level) to LanGT4 of the
landomycin biosynthetic gene cluster from Streptomyces
cyanogenus [17], and also resembles EryCIII (38% identical
at the amino acid level), a glycosyltransferase devoted to
D-desosamine attachment in erythromycin biosynthesis
[18,19], DnrH (38% identical at the amino acid level),
which is involved in daunorubicin biosynthesis [20], and
OleG2 (38% identical at the amino acid level) [21] of the
oleandomycin gene cluster. The urdGT1b gene encodes a
388 aa protein (41.036 kDa), and its initiation codon
appears to be located 17 bases downstream of urdGT1a.
UrdGT1b is closely related to the glycosyltransferases
LanGT1 and LanGT3 from S. cyanogenus (49% and 45%
identical, respectively) [17], OleG2 (32% identical at the
amino acid level) [21] and the mithramycin glycosyltrans-
ferase MtmGII (32% identical at the amino acid level) [22].
The urdGT1c gene encodes a 391 aa protein (40.883 kDa).
UrdGT1c and UrdGT1b share strikingly high homology
(89% identical at the amino acid level). The deduced
amino acid sequence of urdInt was very similar to TnpA, a
transposase of Rhodococcus rhodochrous [23] (69% identical
at the amino acid level), and to an IS116-element trans-
posase of Streptomyces clavuligerus [24] (62% identical at the
amino acid level). UrdInt is flanked by two direct repeats
(DR1 and DR2). Several obvious inverted repeat
sequences were also identified. IR1 and IR2 are located in
the intergenic region downstream of urdGT1c and IR3 is
located between orf157 and orf355 (Figure 2). Within a
150 bp region located upstream of urdGT1a, a motif that
strongly resembles streptomycete promoter consensus
sequences was found [25].
A mutant lacking all three glycosyltransferase genes
predominantly accumulates urdamycinone B and
aquayamycin
Apramycin-resistant colonies were obtained after trans-
forming S. fradiae with plasmid pKC-12-B2. Integration of
pKC-12-B2 into the chromosome was confirmed by
Southern analysis. To allow for the second recombination
event, integrants were screened for apramycin sensitivity.
The chromosomal mutation in mutant Ax, which was sen-
sitive to apramycin, was analyzed by Southern hybridiza-
tion. A 5.2 kb SacI fragment (fragment d in Figure 2) was
used to probe PstI-digested chromosomal DNA. Analysis
of wild-type S. fradiae showed the expected 5.2, 2.6 and
2.4 kb fragments after hybridization. When chromosomal
DNA from mutant Ax was treated similarly, one 2.4 kb
fragment was detected indicating that the 4 kb
BamHI–PstI fragment had been removed (Figure 3a).
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Figure 2
Genetic organization of the urdamycin biosynthetic gene cluster. Genes
are indicated by arrows oriented in the direction of transcription. Genes
encoding glycosyltransferases are red and PKS genes are blue.
Fragments a–d have been used in constructing plasmids for gene-
disruption experiments. (Ba, BamHI; P, PstI; S, SacI; N, NcoI; Bs, BsmI;
DR, direct repeat; IR, inverted repeat.) 
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Polymerase chain reaction (PCR) amplification with chro-
mosomal DNA of mutant Ax as template and primers 1F
and 4R (which are located directly upstream of urdGT1a
and 500 bp downstrean of urdGT1c, respectively) pro-
duced a 1.56 kb fragment, confirming the expected dele-
tion. The Ax mutant did not produce urdamycin, but
instead produced urdamycinone B and aquayamycin
(major products) and urdamycinone C, urdamycinone D
and rabelomycin (minor products; Figure 1 and Table 1). 
A mutant lacking UrdGT1b and UrdGT1c but containing a
hybrid enzyme UrdGT1b/c accumulates the urdamycin
intermediate 100-2 and minor amounts of urdamycinone B
After S. fradiae protoplasts were transformed with plasmid
pBsmSP3, erythromycin-resistant colonies were obtained.
Chromosomal DNA of several colonies was analyzed by
Southern blot using a 5.2 kb SacI DNA fragment (fragment
d in Figure 2) as a probe. Integration of pBsmSP3 by a
single cross-over event should give hybridization signals at
5.2 kb and 2.7 kb after SacI digestion (Figure 3b,c). These
hybridization patterns were obtained in several cases. Chro-
mosomal DNA of one mutant (mutant 16) gave only one
hybridization signal at 2.7 kb, however. The use of a 1.7 kb
SmaI fragment containing the erythromycin-resistance
gene as a probe resulted in one hybridization signal at
4.5 kb after SacI digestion. This hybridization pattern can
be explained by the unusual integration event given in
Figure 3d. To confirm our results, PstI-restricted chromo-
somal DNA of S. fradiae and mutant 16 were subjected to
Southern analysis again using fragment d (Figure 2) as a
probe. Hybridization patterns (S. fradiae, 5.2 kb, 2.6 kb and
2.4 kb; mutant 16, 5.5 kb, 5.2 kb, 2.4 kb and 1.6 kb) were
consistent with the proposed integration event (data not
shown). Mutant 16-14 was generated from mutant 16 after
screening for loss of resistance to erythromycin. Southern
analysis of 16-14 confirmed the presence of the expected
deletion: there was no hybridization signal using the 1.7 kb
SmaI fragment (ermE) as a probe, and only one signal at
2.7 kb when the 5.2 kb SacI DNA fragment was used as a
probe. The analysis of culture supernatants of mutant 16-14
showed that compound 100-2 and minor amounts of
urdamycinone B [26] (Figure 1 and Table 1) were pro-
duced instead of urdamycin A.
A mutant lacking UrdGT1a predominantly accumulates
urdamycin B and 12b-derhodinosyl-urdamycin A
To determine the function of UrdGT1a, mutants were
generated using plasmid pKC33 containing a frame-shift
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Figure 3
Southern hybridization of genomic S. fradiae
DNA. (a) Genomic DNA of the Ax mutant
(lane 1) and wild-type S. fradiae Tü2717
(lane 2) was digested with Pst I and probed
with fragment d (Figure 2). (b,c) Genomic
DNA of wild-type S. fradiae Tü2717 (lane 1),
mutant 16 (lane 2) and mutant 16-14 (lane 3)
was digested with SacI and probed with
fragment d (Figure 2) (b) and the ermE
gene (c). (d) Genomic organization of mutant
16 obtained by integration of pBsmSP3 into
S. fradiae Tü2717 by an unusual integration
event and mutant 16–14 (generated from
mutant 16 by a double cross-over event).
P, PstI; S, SacI; Bs, BsmI.
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mutation within urdGT1a. After transforming S. fradiae pro-
toplasts with pKC33, several apramycin-resistant colonies
were obtained. Two of these colonies were grown on plates
containing no apramycin to select for loss of the resistance
gene. Apramycin-sensitive colonies were obtained, sug-
gesting that they were the consequence of a double cross-
over. Mutant D331-9 was examined further. PCR
fragments obtained from mutant D331-9 could be digested
by BamHI but not by NcoI, whereas PCR fragments
obtained from wild-type DNA could be digested by both
enzymes. Results of the PCR analysis were confirmed by
Southern blot (data not shown). Analysis of culture super-
natants of D331-9 showed that urdamycin B and 12b-der-
hodinosyl-urdamycin A were the predominant products,
instead of urdamycin. Further compounds, detected in
small amounts, were 12b-derhodinosyl-urdamycin C,
12b-derhodinosyl-urdamycin D, and urdamycinone D
[27,28] (Figure 1 and Table 1). 
Complementation of D331-9 with urdGT1a
To determine clearly that the mutation event only
affected urdGT1a and no other genes, urdGT1a was sub-
cloned into pUWL201 and introduced by transformation
into D331-9. In eight of ten transformants urdamycin A
production was restored, indicating that only urdGT1a was
affected by the mutation.
Expression of glycosyltransferase genes in the Ax mutant 
In order to verify (urdGT1a) and specify (urdGT1b and
urdGT1c) the function of the glycosyltransferase genes we
expressed these genes singly and in various combinations.
The genes urdGT1a, urdGT1b and urdGT1c were amplified
by PCR and cloned into the vector pMunII. They were
then cloned as single genes or in combination into the
expression vector pUWL201 (the expression of genes in
this vector is controlled by the erythromycin-resistance pro-
moter (ermE*; [29]; Table 1). Constructs were used to trans-
form the Ax mutant. Urdamycinone B was converted to
100-1 and aquayamycin to 12b-derhodinosyl-urdamycin G
and forward into the corresponding C- and D-analogs after
the expression of urdGT1c, and compound 100-2 was identi-
fied when urdGT1a was expressed. No conversion of
urdamycinone B and aquayamycin was observed after the
expression of urdGT1b alone. Urdamycin G and minor
amounts of 100-1 were produced after coexpression of
urdGT1a and urdGT1c; 12b-derhodinosyl-urdamycin A and
urdamycin B were produced after expression of urdGT1b
and urdGT1c ; and urdamycin A production was restored
after coexpression of urdGT1a, urdGT1b, and urdGT1c
(Figure 4 and Table 1).
Expression of urdGT1c in the 16-14 mutant, which
accumulates compound 100-2
The deletion in mutant 16-14 was leading to the formation
of a hybrid glycosyltransferase gene. The product of this
hybrid gene contains 238 aa of UrdGT1b (amino-terminal
sequence) and 153 aa of UrdGT1c (carboxy-terminal
sequence). The genes urdGT1c and urdGT1b were
expressed separately in mutant 16–14. (Table 1). Trans-
formants containing urdGT1c accumulated urdamycin G
and urdamycin A (Figure 4), indicating that the hybrid
gene was still active.
Discussion
Functions of UrdGT1a, UrdGT1b and UrdGT1c 
The urd PKS genes were originally cloned by homology
with tetracenomycin PKS gene probes. Deletion of the
PKS genes from the chromosome abolished urdamycin
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Table 1
Mutants, glycosyltransferase gene constructs and resulting metabolites.
Mutant Expressed glycosyltransferase(s) Main products produced by the recombinant strain
Wild type – Urdamycin A, urdamycin B, 12b-derhodinosyl-urdamycin A, urdamycin C, urdamycin D
Ax – Aquayamycin, urdamycinone B, urdamycinone C, urdamycinone D, rabelomycin
16-14 – 100-2, urdamycinone B
D331-9 – urdamycin B, 12b-derhodinosyl-urdamycin A,
12b-derhodinosyl-urdamycin C, 12b-derhodinosyl-urdamycin D, urdamycinone D
Ax urdGT1a 100-2, aquayamycine, urdamycinone B
Ax urdGT1b Aquayamycin, urdamycinone B, urdamycinone C, urdamycinone D, rabelomycin
Ax urdGT1c 12b-derhodinosyl-urdamycin G, aquayamycin, 12b-derhodinosyl-4A-deolivosyl-urdamycin C,
12b-derhodinosyl-4A-deolivosyl-urdamycin D, 100-1
Ax urdGT1a + urdGT1c Urdamycin G, 100-1
Ax urdGT1b + urdGT1c 12b-derhodinosyl-urdamycin A, aquayamycin, urdamycin B
Ax urdGT1a + urdGT1b 100-2, aquayamycin, urdamycinone B
Ax urdGT1a + urdGT1b + urdGT1c Urdamycin A, 12b-derhodinosyl-urdamycin A, 100-2
D331-9 urdGT1a Urdamycin A, urdamycin B, urdamycin C, 12b-derhodinosyl-urdamycin C
16-14 urdGT1b 100-2, urdamycinone B
16-14 urdGT1c Urdamycin A, urdamycin G, 100-2, urdamycin C, 12b-derhodinosyl-urdamycin C,
urdamycin B, 100-1
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production, providing evidence that the cloned genes
were indeed those for the urdamycin PKS [9]. These
genes and genes encoding a ketoreductase, a cyclase and
an oxygenase were sequenced. Finding genes apparently
involved in deoxysugar biosynthesis and C-glycosylation
was consistent with this assignment [12]. It has been
shown that urdamycin I, urdamycin J and urdamycin K
were produced by a UrdGT2-mutant, and as these
angucyclines do not contain the C-glycosidic moiety it was
concluded that UrdGT2 must catalyze the C-glycosyl
transfer of an activated D-olivose, which is the first glyco-
syltransfer step in urdamycin A biosynthesis [12,26]. 
Our work was aimed at identifying and elucidating the
function of all glycosyltransferase genes involved in
urdamycin biosynthesis. Analysis of an 8.5 kb DNA frag-
ment identified three putative glycosyltransferase genes.
A mutant in which all three had been deleted accumu-
lated urdamycinone B and aquayamycin. The urdGT1a–
mutant predominantly accumulated urdamycin B, which
does not contain the L-rhodinose moiety at position 12b,
indicating that UrdGT1a is responsible for the transfer of
this 12b-linked L-rhodinose. In the biosynthetic sequence
leading to urdamycin A, this is the glycosylation of
aquayamycin to 100-2, the second glycosyltransfer step
[26]. Comparison of the deduced amino acid sequence of
urdGT1b and urdGT1c showed that these two glycosyl-
transferases are extremely similar to each other—the
amino acid sequences differ in only 33 amino acids (of
which 23 are located in the first 200 amino-terminal
residues). A mutant lacking both genes but containing a
hybrid gene consisting of 715 nucleotides from urdGT1b
and 458 nucleotides from urdGT1c accumulated interme-
diate 100-2, indicating that both UrdGT1b and UrdGT1c
are involved in the formation of the trisaccharide chain. 
In order to distinguish between the functions of urdGT1b
and urdGT1c both genes were expressed separately in the
Ax mutant. Aquayamycin was converted to 12b-derhodi-
nosyl-urdamycin G [30] and forward into the correspond-
ing C- and D-analogs (in which the enlarged chromophore
moieties can be described as 4-hydroxyphenyl-δ-lactone
and as indolyl-δ-lactone, respectively) after the expression
of urdGT1c, and no conversion was observed after the
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Figure 4
Structure of aromatic polyketides produced after expression of glycosyltransferase genes in the Ax mutant.
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expression of urdGT1b. Coexpression of urdGT1b and
urdGT1c in the same mutant resulted in the formation of
12b-derhodinosyl-urdamycin A and urdamycin B [30]
(Figure 4 and Table 1). These experiments allowed the
unambiguous functional assignment of the products of the
urdGT1b and urdGT1c genes. UrdGT1c catalyzes the
transfer of dNDP-L-rhodinose to the first sugar of the
trisaccharide sidechain, that is the formation of urdamycin
G from 100-2, which is the third glycosylation step of the
urdamycin A biosynthesis, and UrdGT1b adds the termi-
nal sugar (dNDP-D-olivose) to complete the biosynthesis
(Figure 4). UrdGT1b and UrdGT1c have relaxed sub-
strate specificity, because they can act on molecules with
or without L-rhodinose at position 12b. 
The functions of all three glycosyltransferase genes was
confirmed by coexpressing urdGT1a and urdGT1c, or
urdGT1a, urdGT1b and urdGT1c in the Ax mutant result-
ing in the formation of urdamycin G or urdamycin
A, respectively. 
We were also interested in investigating whether the
product of the hybrid glycosyltransferase gene in the
16-14 mutant was enzymatically active. After expression of
urdGT1c in mutant 16-14 formation of urdamycin G and
urdamycin A was observed. The formation of urdamycin A
indicates that the hybrid glycosyltransferase, which differs
from UrdGT1b in six amino acids, is enzymatically active
and catalyzes the same reaction as UrdGT1b. As
UrdGT1b and UrdGT1c are very similar in their amino
acid sequences, but transfer different dNDP-deoxysugars
to different alcohol substrates, they should be useful in
exploring the substrate-binding sites for the activated
sugar and the corresponding alcohol substrates. Our plan
in this context is to construct further hybrid glycosyltrans-
ferase genes and test their catalytic activities. 
To enable coexpression of multiple genes in our system, a
special cloning vector (pMunII) was created. This vector
facilitates the construction of gene sets in a convenient
way, taking advantage of the compatibility of MunI and
EcoRI restriction enzymes. Coexpression of several gene
combinations in the Ax mutant was achieved using
pMunII as the cloning vector. 
Urdamycin A was produced when all three glycosyltrans-
ferase genes were expressed, indicating that urdInt,
located between urdGT1b and urdGT1c, is not required for
urdamycin biosynthesis (this gene is also absent in the Ax
mutant). UrdInt, in contrast to IS116, is flanked by two
direct repeats (TGTCA and GAAGA), indicating that the
insertion of urdInt caused target site duplication. The
deduced amino acids DxxDT (in which x denotes any
amino acid) found in UrdInt strongly resemble the motif
DxxDA present in IS110, IS116 and IS900, and also in
reverse transcriptases of retroviral origin. Site-directed
mutagenesis demonstrated that the DxxD motif is func-
tionally important. We cannot conclude that transposition
of urdInt was based on a RNA intermediate, however [24].
The function of genes located upstream of urdGT1a
remains unknown as the deduced amino acid sequences of
both orf157 and orf355 do not resemble any essential
genes involved in any antibiotic biosynthesis.
Significance
The assembly of the saccharide portions of urdamycin A
is controlled by four glycosyltransferases. The function of
each glycosyltransferase gene was determined by gene
inactivation and expression experiments. Some of the gly-
cosyltransferases have flexibility in their substrate speci-
ficity, making them potentially valuable tools for
combinatorial biosynthesis of novel polyketides.
UrdGT1b and UrdGT1c transfer different NDP-sugars
to different alcohol substrates. The fact that these two
glycosyltransferases are highly homologous  (89% identi-
cal at the amino acid level) opens up the possibility for
exploring the substrate and co-substrate binding site
through constructing UrdGT1b/1c hybrid glycosyltrans-
ferases. 
Material and methods
Bacterial strains, plasmids, and culture conditions
S. fradiae Tü2717 [7], obtained from the Department of Microbiology,
University of Tübingen, was grown on 1% malt extract, 0.4% yeast
extract, 0.4% glucose and 1 mM CaCl2, pH 7.2 (HA medium) at 28°C.
E. coli XL1 Blue MRF′ from Stratagene, La Jolla, CA, was used as host
for plasmid propagation. Plasmids were passed through E. coli ET12567
(dam–, dcm–, hsds–, Cm+ ) [31] to generate unmethylated DNA before
their use to transform S. fradiae. E. coli strains were grown under stan-
dard conditions. Plasmid pBluescript SK– (pSK–) was obtained from
Stratagene, plasmid pSP1 [32] was provided by S. Pelzer, Department
of Microbiology, University of Tübingen, pDS101 [33] was from
D. Schwarz, Department of Microbiology, University of Tübingen, and
pKC1132 [34] was from Eli Lilly and Company, Indianapolis, IN.
pUWL201 was a gift from U. Wehmeier and Professor Piepersberg,
Department of Chemical Microbiology, University of Wuppertal.
General genetic manipulation
Routine molecular methods were performed as described previously
[35]. Protoplast formation, transformation, and regeneration of proto-
plasts for S. fradiae were performed following standard procedures
[36]. Digestion of DNA with restriction endonucleases, and southern
hybridization were carried out according to the manufacturer’s direc-
tions (Amersham Pharmacia Biotech, Freiburg, Germany; Boehringer–
Mannheim, Mannheim, Germany).
DNA sequencing and computer assisted sequence analysis
DNA was sequenced by the dideoxynucleotide chain-termination
method with thermo sequenase. Sequencing reactions were performed
on an automated sequencer (Vistra 725) from Molecular Dynamics
(Krefeld, Germany). The GenBank accession number for the sequence
is AF164961. DNA sequences were analyzed using the DNASIS soft-
ware package (version 2, 1995; Hitachi Software Engineering, San
Bruno, CA). Blast X analysis was run with the GenBank CDC transla-
tions + PDB + SwissProt + Spupdate + PIR, release 2.0.
Generation of gene-inactivation plasmids
Generation of pKC-12-B2. A 5.2 kb Pst I (fragment a in Figure 2)
and a 2.4 kb Pst I fragment (fragment b in Figure 2) were ligated into
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pBluescript SK– to create p33 and p12, respectively. A 2.1 kb BamHI
fragment (fragment c in Figure 2) of p33 was ligated into the BamHI
site of the polylinker of p12 to generate p12-B2. A 4.4 kb Hind III–XbaI
fragment of p12-B2 was cloned into the corresponding sites of
pKC1132 generating pKC-12-B2. Fragments b and c (Figure 2) are
adjacent in this plasmid. 
Generation of pBsmSP3. Plasmid pS5, containing a 5.2 kb Sac I
fragment (fragment d in Figure 2) was restriction enzyme digested with
Bsm I to delete a 2630 bp fragment. After religation the resulting
2.6 kb Sac I fragment was subcloned into pDS101 to create pBsm8-
11. To generate pBsmSP3 a 2.6 kb EcoRI–Xba I fragment of pBsm8-
11 containing the entire SacI fragment was ligated into pSP1.
Consequently, pBsmSP3 contains fragment d of Figure 2 containing a
2630 bp Bsm I deletion. 
Generation of pKC33. Plasmid p33 (containing fragment a in
Figure 2) was restricted with NcoI, treated with Klenow fragment and
religated resulting in p33*. Plasmid p33* carries a frame-shift mutation
after the amino-terminal 326 amino acids of UrdGT1a. A 5.2 kb Pst I
fragment containing the frame-shift mutation was ligated into pKC1132
to create pKC33. 
DNA amplification by PCR
Identification of mutants D331-9 and Ax. Oligonucleotide primers
were purchased from Applied Biosystems, Weiterstadt. PCR amplifica-
tion was performed using a GeneAmp PCR System 2400 (Applied
Biosystems, Weiterstadt). The amplification of urdGT1a in the wild-
type strain and in mutant D331-9 was performed using primer
1F: 5′-TGCGTGTAAGCTTTTCGATCATGCCGGCAA-3′ and primer
1F2: 5′-ACGCCAACGACACCAACGGCGTGAAAT-3′. For detecting
mutant Ax, primers 1F (see above) and 4R: 5′-CCATTCTCATCAGC-
GAATTCCAGGATCTGG-3′ were used. PCR conditions were similar
to those described previously [37]. 
Generation of gene expression constructs. A MunI restriction site
5′ to the ribosome binding site and a Bgl II restriction site 3′ to the ter-
mination codon were introduced into the S. fradiae glycosyltransferase
genes (urdGT1a, urdGT1b, and urdGT1c), using PCR. Templates for
the PCR were p33 (for urdGT1a) and pS5 (for urdGT1b and
urdGT1c). The synthetic oligonucleotides used for the amplification of
urdGT1a were primer urdGT1aF, 5′-CTCCAGCAATTGGAGCAGTC-
CATATGCGTG-3′ and primer urdGT1aR, 5′-ACACGCATAGATC-
TACTCCCTGCGTCA-3′; for the amplification of urdGT1b primer
urdGT1bF, 5′-CCGCCGCAATTGCAGGGAGTAGTCATATGCG-3′
and primer urdGT1bR, 5′-CTCCAACCGCCGTAGATCTGACATCA-
3′; and for the amplification of urdGT1c primer urdGT1cF, 5′-CGCC-
CAACAATTGACGGAGACCATATGCGA-3′ and primer urdGT1cR,
5′-CAGACGTACGAGATCTAGGGCCGGCTA-3′. PCR fragments
were cloned into the MunI and Bgl II site of pMunII to create
pMun2urdGT1a, pMun2urdGT1b, and pMun2urdGT1c, respectively.
Plasmid pMunII had been derived from pBluescript SK– by removing
the SmaI, Pst I, EcoRI and EcoRV restriction enzyme sites between the
BamHI and Hind III site of the polylinker and introducing EcoRI, Bgl II,
NdeI, Nsi I, NcoI and MunI sites instead. For expression, fragments
were cloned into the Hind III and XbaI site of pUWL201 to create the
corresponding plasmids pUWLurdGT1a, pUWLurdGT1b and
pUWLurdGT1c. For the coexpression of urdGT1b and urdGT1c
pMun2urdGT1c was restricted with MunI and XbaI and the fragment
containing urdGT1c was ligated into pMun2urdGT1b restricted with
EcoRI and XbaI generating pMun2urdGT1b-1c. After Hind III and XbaI
restriction both genes were cloned into pUWL201 to create
pUWL1b-1c. The constructions of pUWL1a-1b, pUWL1a-1c, and
pUWL1a-1b-1c were performed in a similar way.
Production and purification of urdamycin compounds
All described mutants were grown on agar dishes as well as in liquid
medium to produce their metabolites. The medium for the agar dishes
consisted of 20 g/l soybean meal and 20 g/l glucose dissolved in 1 l of
tap water. The pH was adjusted to 7.00. The mutants were grown for
4 days at 30°C. Medium for liquid cultures (NL111v) consisted of
0.2 g/l Lab-Lemco powder (Oxoid, Hampshire, England), 100 g/l malt
extract and 10 g/l Ca(CO3)2. To isolate the urdamycins, agar medium
was chopped and extracted 5 × with an ethyl acetate:acetone (1:1)
mixture, and liquid medium was extracted 3 × with ethyl acetate. The
organic layer was concentrated to dryness. The obtained crude extract
was separated by HPLC (RP-18 silica gel column, 250 × 10 mm, flow
rate 6 ml/min, using an H2O/acetonitrile/MeOH gradient: 3 min
70:25:5, within 8 min to 60:33.5:6.5, further 10 min at this relation).
Final purification was performed by Sephadex LH-20 chromatography
(column, 100 × 2.5 cm, MeOH).
Chemical analysis of urdamycin intermediates
The 1H nuclear magnetic resonance (NMR) data of the novel
urdamycin C and D derivatives, recorded at 400 MHz in d6-acetone,
are as follows: 12b-derhodinosylurdamycin C 1H NMR (400 MHz,
d6-acetone): d 1.00–2.2 m (2′-Ha), 1.10–1.50 m (2B-H), 1.13 d
(J = 6 Hz, 3H, 5A-CH3), 1.21 s (3H, 3-CH3), 1.21 d (J = 6 Hz, 5B-
CH3), 1.24 d (J = 6 Hz, 3H, 5′-CH3), 1.25–1.7 m (2A-H, 3A-H),
1.9–2.2 m (2A-H, 3A-H and 2B-H, partly obscured by solvent), 2.0
(partly obscured by solvent, 4-He), 2.1 (partly obscured by solvent,
4-Ha), 2.2 ddd (J = 13, 5 and 2 Hz, 1H, 2′-He), 2.55 dd (J = 13 and
2 Hz, 1H, 2-He), 2.8 (partly obscured by water, 4′-H), 2.9 (partly
obscured by water, 2-Ha), 3.08 dq (partly obscured by water, 1H, 5B-
H), 3.10 dd (partly obscured by water, 1H, 4B-H), 3.45 dq (J = 9 and
6 Hz, 1H, 5′-H), 3.52 m (1H, 3B-H), 3.55 s (broad, 1H, 4A-H),
3.76 ddd (J = 12, 8.5 and 5 Hz, 1H, 3′-H), 4.19 dq (J = 6 and 2 Hz,
1H, 5A-H), 4.58 d (J = 11 and 2 Hz, 1H, 1B-H), 4.75 dd (J = 10 and
2 Hz, 1H, 1′-H), 4.98 s (broad, 1H, 1A-H), 6.15 d (J = 10 Hz, 1H, 5-H),
7.05 d (J = 10 Hz, 1H, 6-H), 7.06 d (J = 8 Hz, 2H, 6′-H and 8′-H), 7.4 d
(J = 8 Hz, 2H, 5′-H and 9′-H), 7.88 s (1H, 10-H) ppm.
12b-derhodinosyl-4A-deolivosylurdamycin C 1H NMR (400 MHz,
d6-acetone): d 1.00–2.2 m (2′-Ha), 1.15 d (J = 6 Hz, 3H, 5A-CH3),
1.20 s (3H, 3-CH3), 1.24 d (J = 6 Hz, 3H, 5′-CH3), 1.25–1.7 m (2A-H,
3A-H), 1.9–2.2 m (2A-H, 3A-H, partly obscured by solvent), 2.00
(partly obscured by solvent, 4-He), 2.08 (partly obscured by solvent,
4-Ha), 2.2 ddd (J = 13, 5 and 1.5 Hz, 1H, 2′-He), 2.56 dd (J = 13 and
2 Hz, 1H, 2-He), 2.8 (partly obscured by water, 4′-H), 2.9 (partly
obscured by water, 2-Ha), 3.46 dq (J = 9 and 6 Hz, 1H, 5′-H), 3.55 s
(broad, 1H, 4A-H), 3.79 ddd (J = 12, 9 and 5 Hz, 1H, 3′-H), 4.18 dq
(J = 6 and 2 Hz, 1H, 5A-H), 4.75 dd (J = 10 and 1.5 Hz, 1H, 1′-H),
4.98 s (broad, 1H, 1A-H), 6.15 d (J = 10 Hz, 1H, 5-H), 7.05 d
(J = 10 Hz, 1H, 6-H), 7.06 d (J = 8 Hz, 2H, 6′-H and 8′-H), 7.4 d
(J = 8 Hz, 2H, 5′-H and 9′-H), 7.88 s (1H, 10-H) ppm.
12b-derhodinosylurdamycin D 1H NMR (400 MHz, d6-acetone): d
1.03 d (J = 6 Hz, 3H, 5A-CH3), 1.10 d (J = 6 Hz, 5B-CH3), 1.20–1.7 m
(2′-Ha), 1.20–1.70 m (2B-H), 1.20 s (3H, 3-CH3), 1.21 d (J = 6 Hz, 3H,
5′-CH3), 1.25–1.5 m (2A-H, 3A-H), 1.9–2.2 m (2A-H, 3A-H and 2B-H,
partly obscured by solvent), 1.9 (partly obscured by solvent, 4-Ha), 2.2
(partly obscured by solvent, 4-He), 2.2 m (1H, 2′-He), 2.55 dd (J = 13
and 2 Hz, 1H, 2-He), 2.8 (partly obscured by water, 4′-H), 2.8 (partly
obscured by water, 2-Ha), 2.8 dd (partly obscured by water, 4B-H),
3.19 dq (partly obscured by water, 1H, 5B-H), 3.38 dq (J = 9 and 6 Hz,
1H, 5′-H), 3.49 m (1H, 3B-H), 3.52 s (broad, 1H, 4A-H), 3.75 ddd
(J = 12, 9 and 5 Hz, 1H, 3′-H), 4.18 dq (J = 6 and 2 Hz, 1H, 5A-H),
4.58 d (J = 11 and 2 Hz, 1H, 1B-H), 4.71 dd (J = 10 and 2 Hz, 1H,
1′-H), 4.95 s (broad, 1H, 1A-H), 6.08 d (J = 10 Hz, 1H, 5-H), 7.00 d
(J = 10 Hz, 1H, 6-H), 7.16 ddd (J = 8, 8 and 2 Hz, 1H, 9′-H), 7.21 ddd
(J = 8, 8 and 2 Hz, 1H, 8′-H), 7.59 dd (J = 8 and 2 Hz, 2H, 7′-H and
10′-H), 8.01 s (1H, 5′-H), 8.18 s (1H, 10-H) ppm.
12b-derhodinosyl-4A-deolivosylurdamycin D 1H NMR (400 MHz,
d6-acetone): d 1.05 d (J = 6 Hz, 3H, 5A-CH3), 1.20–1.7 m (2′-Ha),
1.20 s (3H, 3-CH3), 1.20–1.6 m (2A-H, 3A-H), 1.21 d (J = 6 Hz, 3H,
5′-CH3), 1.9–2.2 m (2A-H, 3A-H, partly obscured by solvent), 2.04
(partly obscured by solvent, 4-Ha), 2.1 (partly obscured by solvent, 4-
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He), 2.23 m (1H, 2′-He), 2.56 dd (J = 13 and 2 Hz, 1H, 2-He), 2.8
(partly obscured by water, 4′-H), 2.8 (partly obscured by water, 2-Ha),
3.40 dq (J = 9 and 6 Hz, 1H, 5′-H), 3.52 s (broad, 1H, 4A-H),
3.78 ddd (J = 12, 9 and 5 Hz, 1H, 3′-H), 4.16 dq (J = 6 and 2 Hz, 1H,
5A-H), 4.75 dd (J = 10 and 2 Hz, 1H, 1′-H), 4.98 s (broad, 1H, 1A-H),
6.10 d (J = 10 Hz, 1H, 5-H), 6.98 d (J = 10 Hz, 1H, 6-H), 7.13 ddd
(J = 8, 8 and 2 Hz, 1H, 9′-H), 7.22 ddd (J = 8, 8 and 2 Hz, 1H, 8′-H),
7.59 dd (J = 8 and 2 Hz, 2H, 7′-H and 10′-H), 8.01 s (1H, 5′-H),
8.19 s (1H, 10-H) ppm.
The APCI-MS obtained for 12b-derhodinosyl-urdamycin C (m/z 862.5,
M+, 100%) and the ESI-MS obtained for 12b-derhodinosyl-urdamycin D
(m/z 908.3, M + Na+, 100%) confirmed their molecular formulae. The
accumulation of the new derivative 12b-derhodinosyl-urdamycin G was
only visible in HPLC-UV/Vis, and HPLC-MS, because, during isolation,
this compound converted into 12b-derhodinosyl-4A-deolivosyl-urdamycin
C and D. The analogous nonenzymatic conversion of urdamycin A into
urdamycins C and D has been described previously  [28].
The known urdamycins, their derivatives and aglycones mentioned here
(i.e. urdamycins A, B, C, D, and G, 12b-derhodinosyl-urdamycin A,
urdamycinone B, C and D, 100-1, 100-2, aquayamycin and rabe-
lomycin) were identical in TLC, HPLC-UV/Vis, and HPLC-MS with
those described earlier [8,13,26,27,38–41].
HPLC-MS-ELSD analysis was performed by splitting the flow between
the MS (220 µl) and the ELSD (780 µl) using the following equipment:
HPLC components, 2 × pumps ‘Series 200 micro LC Pump’; High-
Pressure Micro-Mixer (Perkin-Elmer); Autosampler ‘Series 200
Autosampler’ (Perkin-Elmer); solvent degasser, ERC-3215; column
oven, Jetstream plus (ERC), T = 30°C; chromatographic material,
YMC-Pack Pro C-18, 150 x 4.6 mm, 5 µm; mass spectrometer, API
165, Perkin-Elmer-Sciex (single-quadropole); nitrogen generator,
Model 75-77, Whatman; software, Masschrom 1.1.1 (PE-Sciex); Evap-
orative Light-Scattering Detector, Sedex 55 ERC. A linear gradient
from 95% A (5 mM ammonium formiat + 0.1% HCOOH) and 5% B
(MeOH/MeCN = 50/50 + 5 mM ammonium formiat + 0.1% HCOOH)
to 60% A and 40% B in 15 min at 1 ml/min was used. Mass detection:
positive and negative spectra were recorded by fast polarity switching
during the LC-run (150–1500 amu, step size 0.3 amu).
HPLC-UV was performed on a Hewlett Packard 1090 liquid chro-
matograph using a Hewlett Packard C-18 column (2.1 × 200 mm) at a
flow rate of 0.3 ml/min with UV detection at 200–600 nm. Elution was
accomplished with a linear gradient of 5% CH3CN-95% buffer to
58% CH3CN-42% buffer over 45 min. The buffer used was 0.1%
H3PO4 in water. 
Accession number
The sequence reported here has been deposited in the GenBank data-
base under the accession number AF164961. 
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